Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Censoring Survival Data

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

Hazard Rate

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Introduction To Survival Analysis

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...

Survival Tree

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a survival tree begins...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Semi-supervised multi-label feature selection with consistent sparse graph learning.

Neural networks : the official journal of the International Neural Network Society·2026

Same author

A Nested Copula Model for Recurrent Gap Times With a Dependent Terminal Event.

Statistics in medicine·2026

Same author

A 19-layer convolutional neural network for accurate COVID-19 detection in chest X-ray images: comparative analysis with pretrained networks.

Scientific reports·2026

Same author

Interpretable Deep Regression Models With Interval-Censored Failure Time Data.

Statistics in medicine·2026

Same author

Mixed membership latent variable model with unknown factors, factor loadings and number of extreme profiles.

Biometrics·2026

Same author

From mechanisms to management: a comprehensive review of sarcopenia in gastric cancer.

Frontiers in nutrition·2026

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Additive hazards regression with censoring indicators missing at random.

Xinyuan Song¹, Liuquan Sun, Xiaoyun Mu

¹Department of Statistics, Shatin, N. T., Hong Kong, P. R. China.

The Canadian Journal of Statistics = Revue Canadienne De Statistique

|January 4, 2011

Summary

This summary is machine-generated.

This study introduces a new statistical model for analyzing censored data with missing information, improving accuracy in regression analysis for medical research.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Related Experiment Videos

Last Updated: Jun 5, 2026

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Area of Science:

Biostatistics
Survival Analysis
Statistical Modeling

Background:

Analyzing right-censored data is crucial in medical research, especially in clinical trials.
Missing censoring indicators in survival data can introduce bias and reduce statistical power.
Existing methods may not adequately handle situations with missing at random censoring indicators.

Purpose of the Study:

To develop a robust semiparametric additive hazards regression model for right-censored data with missing censoring indicators.
To propose an inverse probability weighted approach for estimating regression parameters under missingness.
To provide a statistically sound method for handling complex survival data scenarios.

Main Methods:

Developed a class of estimating equations tailored for missing censoring indicators.
Employed inverse probability weighting to adjust for missing data.
Utilized nonparametric smoothing for estimating missingness probabilities and conditional probabilities of uncensored observations.
Derived asymptotic properties of the proposed estimators.

Main Results:

The proposed inverse probability weighted estimators demonstrate good performance in simulation studies.
The methods effectively handle right-censored data even when censoring indicators are missing at random.
Asymptotic properties of the estimators were theoretically established.

Conclusions:

The developed semiparametric additive hazards model offers a reliable approach for survival data analysis with missing censoring indicators.
The proposed methodology is applicable to real-world clinical trial data, as demonstrated by the brain cancer study example.
This work contributes to more accurate statistical inference in the presence of incomplete survival data.